Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Dilated cardiomyopathy future or investigational therapies
Introduction
Overview
Overview
New promising treatments for dilated cardiomyopathy include -among others- stem cell-based treatments, cholesterol-lowering drugs in combination with angiotensin receptor blockers, and protein A immunoadsorption.
Future or Investigational Therapies
Future or Investigational Therapies
There are several new therapies, currently under investigation for dilated cardiomyopathy. The most promising of these therapies include:
- Stem cell-based treatments: Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC])
- Cholesterol lowering drugs as Simvastatin or rosuvaststin, alone or in combination with angiotensin receptor blockers as valsartan or olmesartan.
- Protein A Immunoadsorption: an extracorporeal technique used for the removal of IgG antibodies and molecules.
- Other drugs under investigation include Qiliqiangxin, Ranolazine, and Benazepril.[1]
References
References
- ↑ Clinicaltrials.gov. “Currently ongoing trials on new therapies for dilated cardiomyopathies”.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]